Beijing Ganli Pharmaceutical-Shanghai Jiehao Biology Provides High-end Clean Room Equipment for Ganli Pharmaceutical
Beijing Ganli Pharmaceutical-Shanghai Jiehao Biology Provides High-end Clean Room Equipment for Ganli Pharmaceutical
Project Background
Beijing Ganli Biopharmaceutical Co., Ltd., as a leader in the domestic biopharmaceutical industry, has extremely high requirements for the cleanliness of the production environment. In order to meet this demand, Shanghai Jiehao Biotechnology Co., Ltd. provided a series of high-end equipment for its clean room project, including clean room steel doors, VHP transfer windows, self-cleaning transfer windows and weighing covers. These equipment are integrated and managed by CLP IV as the general contractor.
Product Introduction
1.clean room steel door: These doors are all stainless steel construction, which has excellent corrosion resistance and durability. The design of the door ensures air tightness, effectively prevents cross-contamination between areas of different cleanliness levels, and provides the dual advantages of aesthetics and practicality.
2.VHP Transfer Window:VHP delivery window uses vaporized hydrogen peroxide for efficient sterilization, which can sterilize the surface of items at room temperature without harmful residues. Such delivery windows are particularly suitable for the delivery of temperature-sensitive items, such as biologics and the like. The sterilization cycle of VHP delivery window is short, which can effectively reduce the waiting time in production and improve efficiency.
3.self-cleaning transmission hatch: The self-cleaning transfer hatch is self-circulating and purifying the air inside the transferhatch through the high-efficiency filter and fan system to ensure the cleanliness of the transfer items. The double-door interlocking design of the transfer window ensures the effective isolation between the clean area and the non-clean area during the transfer of goods, and prevents cross-contamination.
4.Weighing Hood: The weighing cover provides a local clean environment for the weighing operation. Its working principle is to control the dust and dust in the working area through vertical one-way airflow without spreading to the outside of the operating area, so as to ensure that the operators do not inhale the items they operate and ensure the high cleanliness environment of the working area. The weighing hood is designed to meet the GMP requirements of pharmaceutical factories, ensuring weighing accuracy and safe operation.
Project results
Through the equipment provided by Shanghai Jiehao, the clean room project of Beijing Ganli Biopharmaceutical has successfully realized the high standard requirements of the production environment. These devices not only improve production efficiency, but also ensure product quality and operational safety, laying a solid foundation for the further development of Ganli Pharmaceutical in the field of biopharmaceuticals.
Customer Feedback
Beijing Ganli Biopharmaceutical spoke highly of the equipment and services provided by Shanghai Jiehao. They believe that Shanghai Jiehao's equipment has played a key role in improving the cleanliness and safety of the production environment, while also improving production efficiency and product quality.
Shanghai Jiehao Biotechnology Co., Ltd. has successfully provided a comprehensive solution for Beijing Ganli Biopharmaceutical Clean Room Project with its professional technology and services. This cooperation not only demonstrates the expertise of Shanghai Jiehao in the field of biosafety and clean room equipment, but also demonstrates the leading position of CLP IV in the construction of clean rooms in the biopharmaceutical industry. We look forward to more opportunities to cooperate with CLP IV in the future to jointly promote the development of the biopharmaceutical industry.
Ganli Pharmaceutical Co., Ltd. (stock code: 603087.SH) was established in 1998 and is one of China's leading high-tech biopharmaceutical companies, focusing on the field of diabetes treatment. Headquartered in Beijing, the company has advanced R & D center and production base.
Ganli Pharmaceuticals is mainly engaged in the research and development, production and sales of recombinant insulin analogs and injections. The company has a professional R & D team, and has established cooperative relations with many international well-known enterprises. The products not only occupy a certain share in the domestic market, but also actively expand the international market.
's main products include recombinant insulin glargine (Changxiulin®), recombinant insulin lispro (Suxiulin®), and insulin aspart (Ruixiulin®), covering different types of long-acting, fast-acting and pre-mixed insulin to meet the diverse needs of diabetic patients. In addition, Ganli Pharmaceutical also provides related medical devices, such as insulin injection pens and needles.
Ganli Pharmaceuticals is committed to providing high-quality treatment programs for diabetic patients through continuous technological innovation and product development to improve the quality of life of patients. Companies adhering to the "scientific, extreme" corporate culture, the pursuit of excellence, to become a global leader in the pharmaceutical industry as the goal.
China Electronic System Engineering Fourth Construction Co., Ltd. (referred to as "CLP Fourth Company") was established in 1953 and is affiliated to China System (CESTC) under China Electronics (CEC), one of the world's top 500 companies. It is a company focusing on high-tech industrial engineering Comprehensive service provider in the field. The company's business covers engineering consulting, engineering design, engineering contracting, facility management and product manufacturing, especially in high-tech fields such as semiconductors, flat panel displays, biomedicine, chemical environmental protection, cloud computing and new energy.
CLP No. 4 Company enjoys a good social reputation at home and abroad, and has won many honors such as Luban Award, National Quality Engineering Award, China Installation Star, etc., and has been rated as "National Excellent Construction Enterprise" and "National AAA Credit Enterprise". The company attaches great importance to scientific and technological innovation, has a wealth of patents and standards, as well as a strong professional and technical team.
In the field of biomedical construction, CLP IV has demonstrated its strong strength and professional capabilities. The company has built and served projects of Pfizer, AstraZeneca, Qilu, Merck, Roche, Novartis and other well-known enterprises at home and abroad, reflecting its leading position and influence in the industry. In addition, CLP IV also actively participated in major national strategic projects, such as the construction of nearly 20 new coronary pneumonia vaccine production workshops for enterprises such as Beisheng Institute, Wusheng Institute, Beijing Kexing and Zhifei Bio during the new coronary pneumonia epidemic, making important contributions to the global fight against the epidemic.
CLD is committed to providing customers with high-quality engineering services, contributing more high-quality projects to the society, and making new and greater contributions to the prosperity and development of high-tech industries.
